[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Atyr Pharma Inc (ATYR)

Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Atyr Pharma Inc 10240 Sorrento Valley Road Suite 300 SAN DIEGO CA 92121 USA

www.atyrpharma.com Employees: 58 P: 858-731-8389 F: 858-731-8394

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

aTyr Pharma, Inc. is a bio-therapeutics company. The Company is involved in the discovery and development of medicines for severe, rare diseases of physiological modulators. aTyr Pharma, Inc. is a based in SAN DIEGO, United States.

Key Statistics

Overview:

Market Capitalization, $K 47,790
Enterprise Value, $K 37,050
Shares Outstanding, K 98,051
Float, K 92,413
% Float 94.25%
Short Interest, K 19,845
Short Float 20.24%
Days to Cover 25.28
Short Volume Ratio 0.34
% of Insider Shareholders 5.75%
% of Institutional Shareholders 61.72%

Financials:

Annual Sales, $ 190 K
Annual Net Income, $ -74,120 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -13,960 K
EBIT, $ -77,630 K
EBITDA, $ -77,930 K

Growth:

1-Year Return -87.08%
3-Year Return -78.99%
5-Year Return -89.31%
5-Year Revenue Growth -98.18%
5-Year Earnings Growth 54.80%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.11 on 05/15/26
Next Earnings Date 08/06/26
Earnings Per Share ttm -0.79
EPS Growth vs. Prev Qtr 21.43%
EPS Growth vs. Prev Year 35.29%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-14 on 07/01/19

ATYR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -100.14%
Return-on-Assets % -73.55%
Profit Margin % -39,010.53%
Debt/Equity 0.00
Price/Sales 246.78
Price/Cash Flow N/A
Price/Book 0.81
Book Value/Share 0.69
Interest Coverage -3.21
60-Month Beta 0.66
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.